Viral Hepatitis C in Children
https://doi.org/10.31631/2073-3046-2026-26-2-124-130
Abstract
Relevance. In the world, the study of many aspects of hepatitis C (HC) – epidemiology, diagnostics, clinic, immunology, etc. – the infection remains largely an unresolved problem of public health due to the high prevalence, the difficulty of diagnosing the acute stage of the disease, frequent unfavorable outcomes.
Aims. Analysis of scientific publications concerning the problem of hepatitis C in children.
Material. The review used scientific information databases (eLIBRARY.RU, Cyberleninka, Federal electronic medical library, PubMed). The depth of study is 5 years, with a 20-year retrospective.
Conclusion. The problem of HCV is currently the subject of widespread attention and in-depth study in many countries. In particular, in the Russian Federation, as part of the implementation of the National Strategy for the Elimination of Hepatitis C, a plan has been developed and adopted aimed at a sharp decrease in the incidence of this infection by 2030.
About the Authors
V. G. Akimkin
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation
Russian Federation
Vasily G. Akimkin – Academician of the Russian Academy of Sciences, Dr. Sci. (Med.), Professor, Director
Moscow
Zh. B. Ponezheva
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation
Russian Federation
Zhanna B. Ponezheva – Cand. Sci. (Med.), Head of the Department of Clinical Department of Infectious Pathology
Moscow
H. G. Omarova
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation
Russian Federation
Khadizhat G. Omarova – Cand. Sci. (Med.), Head of the Department of Clinical Research
Moscow
Z. G. Tagirova
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation
Russian Federation
Zarema G. Tagirova – Dr. Sci. (Med.), Head of the Department of Clinical Research
Moscow
S. V. Ugleva
Institute of Disinfection of the FNTSG named after F.F. Erisman of Rospotrebnadzor
Russian Federation
Russian Federation
Ugleva Svetlana V., Dr. Sci. (Med.), Associate Professor
Moscow
S. V. Shabalina
Central Research Institute of Epidemiology of Rospotrebnadzor
Russian Federation
Russian Federation
Svetlana V. Shabalina – Dr. Sci. (Med.), Professor, Leading Researcher of the Clinical Department of Infectious Pathology
Moscow
References
1. EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020 Nov;73(5):1170–1218. doi: 10.1016/j.jhep.2020.08.018.
2. On the State of Sanitary and Epidemiological Well-Being of the Population in the Russian Federation in 2024: State Report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2025. (In Russ.).
3. Hepatitis C. Key facts: WHO, 2020. Доступно на https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
4. Galova E. A. Long-term dynamics of the incidence of chronic viral hepatitis C in children in the Russian Federation. Health Care of the Russian Federation. 2019; 63(6):292– 299. (In Russ.). DOI: http://dx.doi.org/10.18821/0044-197X-2019-63-6-292-299
5. World Health Organization. Guidelines for the screening, care, and treatment of persons with chronic hepatitis C infection, 2019. Available at: https://apps.who.int/iris/bitstream/handle/10665/111747/9789241548755_eng.pdf?sequence=1
6. Ponezheva Zh. B., Akimkin V. G., Mannanova I. V., et al. Relationship of immunological parameters with the severity of liver fibrosis in patients with chronic hepatitis C. Epi- demiology and Infectious Diseases. Current Issues. 2023; 13(1):78–82. (In Russ.). https://dx.doi.org/10.18565/epidem.2023.13.1.78-82
7. 2020 statistics on hepatitis C: do patients know about their diagnosis? 2020. (In Russ.). Available at: https://gepatit-abc.ru/statistika-gepatita-s-za-2020-god-znayut-lipacienty-o-svoem-diagnoze/
8. Bokhonov M. S., Galitsina L. E., Sitnikov I. G., et al. Clinical Features of Chronic Hepatitis C in Children. Children’s Infections. 2023; 22(2):23–27. (In Russ.).doi.org/10.22627/2072-8107-2023-22-2-23-27
9. Davidovich N. V., Solovyova N. V. Immune response in viral hepatitis C: the leading role of natural killers. Bulletin of the Northern (Arctic) Federal University. 2015; 4: 68–78. (In Russ.).
10. Vajro P., Veropalumbo C., Maddaluno S., et al. Treatment of children with chronic viral hepatitis: what is available and what is in store. World J. Pediatr. 2013; 9 (3): 212–220
11. Khamis HH, Farghaly AG, Shatat HZ, El-Ghitany EM. Prevalence of hepatitis C virus infection among pregnant women in a rural district in Egypt. Tropical Doctor. 2016; 46 (1): 21–27. doi: 10.1177/0049475514561330.
12. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update. Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr. 2020 Sep; 71(3):407–417. doi: 10.1097/MPG.00
13. Kim H.S., El-Serag H.B. The epidemiology of hepatocellular carcinoma in the USA. Curr. Gastroenterol. Rep. 2019; 21(4):17–22. Doi: https://doi.org/10.1007/s11894-019-0681-x
14. Ventslovate N. D., Goryacheva L. G., Greshnyakova V. A., et al. Viral hepatitis C in children: retrospective analysis and future prospects. Clinical Infectology and Parasitology. 2021;10(2):208–218. (In Russ.).
15. Leibman E. A., Nikolaeva L. I., Samokhvalov E. I., et al. Features of the course of hepatitis C in children depending on the virus subtype. Epidemiology and Vaccinal Prevention. 2015;1:49–55. (In Russ.).
16. Gower E., Estes C.C., Hindman S., et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 2014. 61: S45–S47.
17. Volynets G. V., Potapov A. S., Skvortsova T. A. Chronic Viral Hepatitis C in Children: Problems and Prospects. Bulletin of the Russian Academy of Medical Sciences. 2014; 11–12: 46–53. (In Russ.).
18. Esaulenko E. V., Vetrov T. A., Dunaev N. V., et al. Distribution of hepatitis C virus genotypes in St. Petersburg. Viral hepatitis: perspective and development. 2014;1:14–16. (In Russ.).
19. Nikolaeva L. I., Toychuev R. M., Leibman E. A., et al. Factors Affecting the Course of Chronic Hepatitis C in Children. Epidemiology and Vaccinal Prevention. 2013; 6: 37–44. (In Russ.).
20. Akimkin V. G., Ponezheva Zh. B., Omarova Kh. G., et al. Viral hepatitis C in pregnant women and newborns. Infectious Diseases, 2023, 21(1)114–118. (In Russ.).
21. Goryacheva L. G., Greshnyakova V. A., Rogozina N. V., et al. Perinatal Viral Hepatitis C and Its Treatment Options. Epidemiology and Infectious Diseases. 2014; 18 (2): 4–8. (In Russ.).
22. Andes A, Ellenberg K, Vakos A, et al. Hepatitis C Virus in Pregnancy: A Systematic Review of the Literature. Am J Perinatol. 2021 Aug;38(S 01):e1–e13. DOI: 10.1055/s-0040-1709672
23. McCormick CA, Domegan L, Carty PG, et al. Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study. BJOG. 2022 Jan;129(2):322–327. DOI: 10.1111/1471-0528.16984
24. Aboubakar M, Kpossou AR, Glago BRGH, et al. Prévalence et facteurs associés au portage des anticorps anti-VHC chez des femmes enceintes à Cotonou [Prevention and factors associated with anti-ВГС carriage in pregnant women living in Cotonou]. Pan Afr Med J. 2020 Jul 14;36:182. DOI: 10.11604/pamj.2020.36.182.23122 [ In French]
25. Walker KF, Bugg G, Macpherson M, et al. Induction of labour versus expectant management for nulliparous women over 35 years of age: a multi-centre prospective, ran- domised controlled trial. BMC Pregnancy Childbirth. 2012 Dec 11;12:145. DOI: 10.1186/1471-2393-12-145
26. Resolution No. 4 of the Chief State Sanitary Inspector of the Russian Federation dated January 28, 2021 (as amended on May 25, 2022), approving the sanitary rules and regulations SanPiN 3.3686-21 «Sanitary and Epidemiological Requirements for the Prevention of Infectious Diseases». (In Russ.).
27. Jhaveri R, Hashem M, El-Kamary SS, et al. Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors. Open Forum Infectious Diseases. 2015; 2 (2): ofv089. doi: 10.1093/ofid/ofv089.89
28. Kushner T, Terrault NA. Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care. Hepatol Commun. 2018 Nov 30;3(1):20–28. DOI: 10.1002/hep4.1282
29. Aebi-Popp K, Duppenthaler A, Rauch A, et al. Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland. Journal of Virus Eradication. 2016; 2 (1): 52–54.
30. Elrazek A, Amer M, El-Hawary B, et al. Prediction of HCV vertical transmission: what factors should be optimized using data mining computational analysis. Liver interna- tional: official journal of the International Association for the Study of the Liver. 2017; 37 (4): 529–533. doi: 10.1111/liv.13146.
31. Ades, AE ∙ Gordon, F ∙ Scott, K, et al. Overall vertical transmission of hepatitis C virus, transmission net of clearance, and timing of transmission. Clin Infect Dis. 2023; 76:905 912
32. Mavilia MG, Wu GY. Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis. Journal of Clinical and Translational Hepatology. 2017; 5 (2): 119–129. doi: 10.14218/JCTH.2016.00067
33. Belopolskaya M.A. Viral hepatitis C and pregnancy. Bulletin of the Peoples’ Friendship University of Russia. Series: Medicine. 2011; 5: 111–117. (In Russ.).
34. Cottrell EB, Chou R, Wasson N, et al. Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2013; 158 (2): 109–113
35. Khamatova A. A., Mazus A. I., et al. Prevalence of HIV/HCV co-infection in pregnant women. Risk factors for perinatal transmission of HIV/HCV. Infectious Diseases. 2022;20(1):91–98. (In Russ.).
36. Yakimova A. V., Mukhamedshina V. R., Kucherenko S. G. Viral hepatitis C in pregnancy: prevalence, impact on perinatal outcomes, and management tactics (literature review). Consilium Medicum. 2022;24(7):477–480. DOI: 10.26442/20751753.2022.7.201799
37. Mast EE, Hwang LYu, Dexter SY, et al. Risk Factors for Perinatal Transmission of Hepatitis C Virus (HCV) and the Natural History of HCV Infection Acquired in Infancy. The Journal of Infectious Diseases 2005; 192:1880–9
38. Epstein RL, Sabharwal V, Wachman EM, et al. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J. Pediatr. 2018; 203: 34–40.e1. doi: 10.1016/j.jpeds.2018.07.006.
39. Pfaender S, Heyden J, Friesland M, et al. Inactivation of hepatitis C virus infectivity by human breast milk. The Journal of Infectious Diseases. 2013; 208 (12): 1943–1952 doi: 10.1093/infdis/jit519.
40. Mok J, Pembrey L, Tovo PA, Newell ML. European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed. 2005 Mar;90(2):F156–60. DOI: 10.1136/adc.2004.059436
41. Panagiotakopoulos, L, ∙ Sandul, AL, ∙ Conners, EE , et al. CDC recommendations for hepatitis C testing among perinatally exposed infants and children – United States, 2023. MMWR Recomm Rep. 2023; 72:1–21
42. Galoppo M., Galoppo C. Management of hepatitis C virus infection in childhood. Ann. Hepatol. 2010; 9 (1): 98–102.14.
43. Mohan N., González-Peralta R.P., Fujisawa T., et al.Chronic hepatitis C virus infection in children. J. Pediatr. Gastroenterol. Nutr. 2010; 50 (2): 123–131.
44. Kuzmin V. N. Viral hepatitis C in pregnant women: a modern problem of obstetrics. Lechashchiy vrach. 2012; 3: 27–32. (In Russ.).
45. Jhaveri R, Hashem M, El-Kamary SS, et al. Hepatitis C Virus Vertical Transmission in 12-Month Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors. Open Forum Infect Dis. 2015;2(2):ofv089.
46. Kerkar N, Hartjes K. Hepatitis C Virus – Pediatric and Adult Perspectives in the Current Decade. Pathogens 2025, 14(1), 11. https://doi.org/10.3390/pathogens14010011
47. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2005; 4 (1): 45–51.
48. Ko SC, Fan L, Smith EA, et al. Estimated Annual Perinatal Hepatitis B Virus Infections in the United States, 2000–2009. Journal of the Pediatric Infectious Diseases Society. 2016; 5 (2): 114–121. doi: 10.1093/jpids/piu115.
49. Ghamar Chehreh M.E., Tabatabaei S.V., Kanehara S., Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIVmothers: a meta-analysis. Arch. Gynecol Obstet. 2011; 283 (2): 255–260.
50. Indolfi G., Azzari C., Resti M. Perinatal Transmission of Hepatitis C Virus. J. Pediatr. 2013; 163 (6): 1549–1552. 51.
51. European Paediatric Hepatitis C Virus Network. A significant sex, but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. The Journal of Infectious Diseases. 2005; 11 (192): 1872–1879.
52. Airoldi J, Berghella V. Hepatitis C and pregnancy. Obstetrical & Gynecological Survey. 2006; 61 (10): 666–672.
53. European Association for Study of Liver/ EASL Recommendations on Treatment of Hepatitis C. Journal of Hepatology/2015; 63 (1):199–236.
54. Mohan N., et al. Clinical spectrum and natural history of chronic hepatitis C virus infection in children. Journal of Pediatric Gastroenterology and Nutrition. 2019;68(3):376– 382. DOI: 10.1097/MPG.00000000000002198.
55. Kuncio DE, Newbern EC, Johnson CC, Viner KM. Failure to Test and Identify Perinatally Infected Children Born to Hepatitis C Virus-Infected Women. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2016; 62 (8): 980–985. doi: 10.1093/cid/ciw026.
56. Rakhmanova A. G., Yakovlev A. A., Kashchenko V. A., et al. Chronic Viral Hepatitis C and Liver Cirrhosis. St. Petersburg: SpetsLit, 2016: 348. (In Russ.).
57. Westbrook RH, Dusheiko G. Natural history of Нepatitis C. Journal of Hepatology. 2014; 61 (1): 58–68.
58. Indolfi G., et al. Hepatitis C virus infection in children and adolescents. The Lancet Gastroenterology & Hepatology. 2019;4(6):477–487.
59. Kisteneva L. B., Cheshik S. G., Samokhvalov E. I., et al. Perinatal Hepatitis C: Comprehensive Assessment of Risk Factors. Russian Bulletin of Perinatology and Pediatrics. 2012;2:58–63. (In Russ.).
60. Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol. 2021 Mar 28;27(12):1117–1131. doi: 10.3748/wjg.v27.i12.1117. PMID: 33828389; PMCID: PMC8006101.
61. Hepatitis C in Russia: A National Strategy is Needed. Available at: https://itpcru.org/2021/04/22/gepatit-s-v-rossii-nuzhna-naczionalnaya-strategiya/
62. WHO. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. World Health Organization, Geneva, Switzerland, 2022. Available at: https://iris.who.int/bitstream/handle/10665/360348/9789240053779-eng.pdf?sequence=1
63. WHO Global hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization, Geneva, 2024. Available at: https://www.who.int/publications/i/item/9789240091672
Review
For citations:
Akimkin V.G., Ponezheva Zh.B., Omarova H.G., Tagirova Z.G., Ugleva S.V., Shabalina S.V. Viral Hepatitis C in Children. Epidemiology and Vaccinal Prevention. 2026;25(2):124-130. (In Russ.) https://doi.org/10.31631/2073-3046-2026-26-2-124-130
Views:
276
JATS XML
Email this article 